Latest Acquisition News

Enero Group’s 2025 AGM revealed a modest revenue dip but a rise in EBITDA, driven by operational improvements and AI innovation. The company’s FY26 Q1 update signals robust momentum with margin expansion and strategic client wins.

Treasury Wine Estates reported robust fiscal 2025 results driven by luxury wine growth and acquisitions, yet has downgraded its fiscal 2026 earnings outlook due to weakening demand in China and distribution disruptions in California.

Mount Gibson Iron Limited has agreed to acquire a 50% interest in the Central Tanami Gold Project, marking a strategic shift towards gold production while maintaining steady iron ore operations at Koolan Island.

Blue Star Helium Limited is advancing its Galactica helium project in Colorado, aiming for initial commercial production by December 2025, supported by a recent A$4.5 million equity raise.

NSX Limited’s shares have been suspended from trading following Federal Court approval of its acquisition by an Ontario-based entity linked to CNSX Markets Inc. This marks a significant shift in ownership for the Australian stock exchange operator.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.

Peppermint Innovation Limited (PIL) has addressed recent unusual trading activity, attributing it to growing market recognition of its recent fintech milestones rather than undisclosed information.

NSX Limited confirms the legal effectiveness of its acquisition by a Canadian entity, with trading suspended and shareholder payments scheduled.

Biotron Limited is set to acquire Sedarex Limited, gaining global patents for SedRx, a next-generation general anaesthetic, supported by a $2.5 million capital raising to fund regulatory and development milestones.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.

Pinnacle Minerals Limited has had its trading suspension lifted following a significant announcement about an acquisition and capital raise, signaling renewed momentum for the mining explorer.